Drug Information Analysis Service

Schooley RT . Cytomegalovirus in the setting of infection with human immunodeficiency virus. Rev Infect Dis 1990; 12 (suppl 7): 811–9.

Balfour HH. Jr. Management of cytomegalovirus disease with antiviral drugs. Rev Infect Dis 1990; 12 (suppl 7): 849–60.

Henry K Cantrill HL Fletcher C Chinnock BJ Balfour HH. Jr. Use of intravitreal ganciclovir (dihydroxy propoxymethyl guanine) for cytomegalovirus retinitis in patients with AIDS. Am J Ophthalmol 1987; 103: 17–23.

Cantrill HL Jr Henry K Melroe NH Knobloch WH Ramsay RC Balfour HH. Jr. Treatment of cytomegalovirus retinitis with intravitreal ganciclovir, long term results. Ophthalmology 1989; 96: 367–74.

Heinemann MH . Long term intravitreal ganciclovir therapy for cytomegalovirus retinopathy. Arch Ophthalmol 1989; 107: 1767–72.

Orellana J Liberman RM Peairs R Restreppo S. Intravitreal therapy for posterior pole cytomegalovirus retinitis in AIDS patients (letter). Br J Ophthalmol 1990; 74: 511.

Ussery FM III Gibson SR Conklin RH Piot DF Stool EW Conklin AJ . Intravitreal ganciclovir in the treatment of AIDS-associated CMV retinitis. Ophthalmology 1988; 95: 640–8.

Cochereau-Massin I LeHoang P Lautier-Frau M Zazoun L Marcel P Robinet M. , Cytomegalovirus retinitis in AIDS: Treatment with intravitreal injections of ganciclovir. Presse Med 1990; 19: 1313–6.

Pulido J Peyman GA Lesar T Vernot J. Intravitreal toxicity of hydroxyacyclovir (BW-B759U, ganciclovir), a new antiviral agent. Arch Ophthalmol 1985; 103: 840–1.

Yoshizumi MO Lee D Vinci V Fajardo S. Ocular toxicity of multiple intravitreal DHPG injections. Graefes Arch Clin Exp Ophthalmol 1990; 228: 350–5.

Bond WS . Recognition and treatment of attention deficit disorder. Clin Pharm 1987; 6: 617–24.

Zametkin AJ Borcherding BG . The neuropharmacology of attention-deficit hyperactivity disorder. Ann Rev Med 1989; 40: 447–51.

Zametkin AJ Nordahl TE Gross M. , Cerebral glucose metabolism in adults with hyperactivity of childhood onset. N Engl J Med 1990; 323: 2361–6.

Calis KA Grothe DR Elia J. Attention-deficit hyperactivity disorder. Clin Pharm 1990; 9: 632–42.

Henker B Whalen CK . Hyperactivity and attention deficits. Am Psychol 1989; 44: 216–23.

Shaywitz SE Shaywitz BA . Diagnosis and management of attention deficit disorder: A pediatric perspective. Ped Clin North Am 1984; 31: 429–57.

Munoz-Millan RJ Casteel CR . Attention-deficit hyperactivity disorder: Recent literature. Hosp Community Psychiatry 1989; 40: 699–707.

Stevenson RD Wolraich ML . Stimulant medication therapy in the treatment of children with attention deficit hyperactivity disorder. Pediatr Clin Am 1989; 36: 1183–97.

Meller W Lyle K. Attention deficit disorder in childhood. Prim Care 1987; 14: 745–59.

Hunt RD Minderaa RB Cohen DJ . Clonidine benefits children with attention deficit disorder and hyperactivity: Report of a double-blind placebo-crossover therapeutics trial. J Am Acad Child Psychiatry 1985; 24: 617–29.

Jacobvitz D Sroufe AL Stewart M. , Treatment of attentional and hyperactivity problems in children with sympathomimetic drugs: A comprehensive review. J Am Acad Child Adolesc Psychiatry 1990; 29: 677–88.

Weiss G. Hyperactivity in childhood (editorial). N Engl J Med 1990; 323: 1413–5.

Deutsch CK Swanson JM Bruell JH Cantwell DP Weinberg F Baren M. Over representation of adoptees in children with the attention deficit disorder. Behav Genet 1982; 12: 231–8.

Murphy VA Serrano Bubica G. General pediatric therapy. Attention deficit disorders. In: Young LY Koda-Kimble MA , eds. Applied therapeutics. Vancouver: Applied Therapeutics, 1988: 1850.

Piepho RW Hill JW . Attention deficit disorders. In: Herfindal ET Gourley DR Hart LL , eds. Clinical pharmacy and therapeutics. Baltimore: Williams and Wilkins, 1988: 661–8.

Mental Health Committee, Canadian Paediatric Society. Use of methylphenidate: An open pilot study in ADD-H. Can Med Assoc J 1990; 142: 817–8.

Zametkin AJ Rapoport JL . Neurobiology of attention deficit disorder with hyperactivity. Where have we come in 50 years? J Am Acad Child Adolesc Psychiatry 1987; 26: 676–86.

Wender PH Reimherr FW . Bupropion treatment of attention-deficit hyperactivity disorder in adults. Am J Psychiatry 1990; 147: 1018–20.

Abramowicz M , ed. Sudden death in children treated with a tricyclic antidepressant. Med Lett Drugs Ther 1990; 32: 53.

Riddel MA Nelson JC Kleinman CS , Sudden death in children receiving norpramin: A review of three reported cases and commentary. J Am Acad Child Adolesc Psychiatry 1990; 30: 104–8.

Hunt RD . Treatment effects of oral and transdermal Clonidine in relation to methylphenidate: An open pilot study in ADD-H. Psychopharmacol Bull 1987; 23: 111–4.

Podolsky DK Isselbacher KJ . Cirrhosis of the liver. In: Wilson JD Braunwald E Isselbacher KJ , Harrison's principles of internal medicine, 12th ed. New York: McGraw-Hill, 1987: 1346–7.

Graham DY Smith JL . The course of patients after variceal hemorrhage. Gastroenterology 1981; 80: 800–9.

Lebrec D Poynard T Hillon P Benhamou JP . Propranolol for prevention of recurrent gastrointestinal bleeding in patients with cirrhosis. N Engl J Med 1981; 305: 1371–4.

Lebrec D Poynard T Bernuau J. , A randomized controlled study of propranolol for prevention of recurrent gastrointestinal bleeding in patients with cirrhosis: A final report. Hepatology 1984; 4: 355–8.

Lebrec D Poynard T Bernuau J. , A randomized controlled study of propranolol for prevention of recurrent gastrointestinal bleeding in patients with cirrhosis. Drugs 1989; 37 (suppl): 30–4.

Sheen IS Chen TY Liaw YF . Randomized controlled study of propranolol for prevention of recurrent esophageal varices bleeding in patients with cirrhosis. Liver 1989; 9: 1–5.

Colombo M DeFranchis R Tommasini M Sangiovanni A Dioguardi N. β-blockade prevents recurrent bleeding in well compensated patients with alcoholic cirrhosis: A multicenter randomized controlled trial. Hepatology 1989; 9: 433–8.

Kiire CF . Controlled trial of propranolol to prevent recurrent variceal bleeding in patients with non-cirrhotic portal fibrosis. Br Med J 1989; 298: 1363–5.

Garden OJ Mills PR Birnie GG Murray GD Carter DC . Propranolol in prevention of recurrent variceal hemorrhage in cirrhotic patients. Gastroenterology 1990; 98: 185–90.

Burroughs AK Jenkins WJ Sherlock S. , Controlled trial of propranolol for the prevention of recurrent variceal hemorrhage in patients with cirrhosis. N Engl J Med 1983; 309: 1539–42.

Villeneuve JP Pomier-Layrargues G Infante-Rivard C. , Propranolol for the prevention of recurrent variceal hemorrhage: A controlled trial. Hepatology 1986; 6: 1239–43.

Poynard T Lebrec D Hillon P. , Propranolol for prevention of recurrent gastrointestinal bleeding in patients with cirrhosis: A prospective study of factors associated with rebleeding. Hepatology 1987; 7: 447–51.